1.0Journal of Medical Ethics bloghttps://blogs.bmj.com/medical-ethicsowenschaeferhttps://blogs.bmj.com/medical-ethics/author/owenschaefer/Opportunities Lie Within Beqvez’s Discontinuation - Journal of Medical Ethics blogrich600338<blockquote class="wp-embedded-content" data-secret="jEGlVuVLr8"><a href="https://blogs.bmj.com/medical-ethics/2025/04/03/opportunities-lie-within-beqvezs-discontinuation/">Opportunities Lie Within Beqvez’s Discontinuation</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://blogs.bmj.com/medical-ethics/2025/04/03/opportunities-lie-within-beqvezs-discontinuation/embed/#?secret=jEGlVuVLr8" width="600" height="338" title="“Opportunities Lie Within Beqvez’s Discontinuation” — Journal of Medical Ethics blog" data-secret="jEGlVuVLr8" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://blogs.bmj.com/medical-ethics/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
By Rafael Escandon Pfizer announced, surprisingly, on February 20, that they plan to discontinue commercial availability of Beqvez, their recently approved gene therapy (GT) for Hemophilia B. They also announced, in separate communications in mid and late 2024, their terminations of investments in a partnership for a Hemophilia A GT, and their discontinuation of a [...]Read More...